Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Eva M Wagner, Lukas A Schaefer, Tobias Bopp, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer

Blood (2012) 120 (21): 3059.

https://doi.org/10.1182/blood.V120.21.3059.3059

Published: 2012

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Long-Term Persistence of Functionally Altered GPI-Anchor Negative T-Cell Subsets After Alemtuzumab-Based T-Cell Depleted Hematopoietic Stem Cell Transplantation.

Eva M Wagner, Aline N Lay, Timo Schmitt, Julia Hemmerling, Diana Wolff, Christoph Huber, Wolfgang Herr, Ralf G Meyer

Blood (2009) 114 (22): 2438.

https://doi.org/10.1182/blood.V114.22.2438.2438

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation for Hodgkin's Disease From Sibling and Unrelated Donors: The German Cooperative Transplantation Study Group Experience.

Blood (2009) 114 (22): 2293.

https://doi.org/10.1182/blood.V114.22.2293.2293

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

Journal Articles

Compassionate Use of Sorafenib in Relapsed and Refractory Flt3-ITD Positive Acute Myeloid Leukemia.

Stephan Metzelder, Sebastian Scholl, MD, Kröger Matthias, Andreas Reiter, MD, Ralf G. Meyer, Thomas Heinicke, Aristoteles Giagounidis, Brugger Wolfgang, Mathias Vöhringer, Michael Stadler, MD, Beate Schultheis, Lothar Müller, Mathias Hänel, Andreas Hochhaus, MD, Erich Enghofer, PhD, Andreas Neubauer, Andreas Burchert

Blood (2009) 114 (22): 2060.

https://doi.org/10.1182/blood.V114.22.2060.2060

Published: 2009

Journal Articles

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules

Eva Distler, Anna Jürchott, Abdo Konur, Astrid Schneider, Eva M. Wagner, Christoph Huber, Ralf G. Meyer, Wolfgang Herr

Blood (2008) 112 (11): 2936.

https://doi.org/10.1182/blood.V112.11.2936.2936

Published: 2008

Journal Articles

Reconstitution of CD52-Negative CD4 T Cells after Alemtuzumab-Based T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Eva M Wagner, MD, Aline N Lay, Sina Wenzel, Timo Schmitt, Julia Hemmerling, Abdo Konur, PhD, Klaus Bender, PhD, Christoph Huber, MD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2008) 112 (11): 1182.

https://doi.org/10.1182/blood.V112.11.1182.1182

Published: 2008

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Ralf G Meyer, MD, Eva M Wagner, MD, Timo Schmitt, Klaus Bender, PhD, Udo F Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2008) 112 (11): 2160.

https://doi.org/10.1182/blood.V112.11.2160.2160

Published: 2008

Journal Articles

Rapid Detection and Isolation of Viable Virus-Reactive CD4 + and CD8 + T Cells Based on Activation-Induced CD137 Expression.

Thomas C. Wehler, Michael Karg, Abdo Konur, Marion Nonn, Ralf G. Meyer, Christoph Huber, Udo F. Hartwig, Wolfgang Herr

Blood (2007) 110 (11): 1972.

https://doi.org/10.1182/blood.V110.11.1972.1972

Published: 2007

Journal Articles

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Timo Schmitt, Kerstin Schneiker, Abdo Konur, PhD, Ali Hadian, MD, Klaus Bender, PhD, Esther von Stebut, MD, Karin Kolbe, MD, Christoph Huber, MD, Wolfgang Herr, MD, Ralf G. Meyer, MD

Blood (2007) 110 (11): 3249.

https://doi.org/10.1182/blood.V110.11.3249.3249

Published: 2007

Journal Articles

Rapid Expansion of Acute Myeloid Leukemia-Reactive Cytotoxic T Cells from CD8+CD62L+ Blood Lymphocytes of HLA-Matched Healthy Donors In Vitro

Eva Distler, Catherine Woelfel, PhD, Sylvia Pesth, Nina Kraus, Thomas C. Wehler, MD, Ralf G. Meyer, MD, Marion Nonn, PhD, Christoph Huber, MD, Thomas Woelfel, MD, Wolfgang Herr, MD

Blood (2006) 108 (11): 3238.

https://doi.org/10.1182/blood.V108.11.3238.3238

Published: 2006

Journal Articles

A PCR-Based Assay for the Detection of Langerhans-Cell Chimerism after Allogeneic Stem Cell Transplantation.

Ralf G. Meyer, MD, Shahrzad Bakhtiar, Klaus Bender, PhD, Timo Schmitt, Abdo Konur, PhD, Christoph Huber, MD, Wolfgang Herr, MD

Blood (2006) 108 (11): 3205.

https://doi.org/10.1182/blood.V108.11.3205.3205

Published: 2006

Journal Articles

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Ralf G. Meyer, Cedrik M. Britten, Daniela Wehler, Klaus Bender, Georg Hess, Abdo Konur, Udo F. Hartwig, Thomas C. Wehler, Andrew J. Ullmann, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, Wolfgang Herr

Blood (2006) 109 (1): 374–382.

https://doi.org/10.1182/blood-2006-03-005769

Published: 2006

Journal Articles

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines

Thomas C. Wehler, Marion Nonn, Britta Brandt, Cedrik M. Britten, Mark Gröne, Mariya Todorova, Irina Link, Shamsul A. Khan, Ralf G. Meyer, Christoph Huber, Udo F. Hartwig, Wolfgang Herr

Blood (2006) 109 (1): 365–373.

https://doi.org/10.1182/blood-2006-04-014100

Published: 2006

Journal Articles

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Ralf G. Meyer, MD, Cedrik M. Britten, MD, Abdo Konur, PhD, Klaus Bender, PhD, Daniela Wehler, MD, Udo Hartwig, PhD, Thomas C. Wehler, MD, Chiara Gentilini, MD, Lutz Uharek, MD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2005) 106 (11): 297.

https://doi.org/10.1182/blood.V106.11.297.297

Published: 2005

Journal Articles

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Ralf G. Meyer, MD, Daniela Wehler, MD, Thomas C. Wehler, MD, Cedrik M. Britten, MD, Alexander Burchardt, MD, Udo Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2004) 104 (11): 5069.

https://doi.org/10.1182/blood.V104.11.5069.5069

Published: 2004

Journal Articles

Characterization of Renal-Cell Carcinoma (RCC)-Reactive Cytotoxic T-Lymphocyte Responses Generated from Peripheral Blood of HLA-Matched Sibling and Unrelated Healthy Individuals in Vitro.

Mark Groene, Sandra Kausche, Elke Schnuerer, Volker Lennerz, PhD, Ralf G. Meyer, MD, Thomas C. Wehler, MD, Andreas Doerrschuck, PhD, Christoph Huber, MD, Christine Falk, PhD, Wolfgang Herr, MD

Blood (2004) 104 (11): 4971.

https://doi.org/10.1182/blood.V104.11.4971.4971

Published: 2004

NARROW

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Long-Term Persistence of Functionally Altered GPI-Anchor Negative T-Cell Subsets After Alemtuzumab-Based T-Cell Depleted Hematopoietic Stem Cell Transplantation.

Allogeneic Stem Cell Transplantation for Hodgkin's Disease From Sibling and Unrelated Donors: The German Cooperative Transplantation Study Group Experience.

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Compassionate Use of Sorafenib in Relapsed and Refractory Flt3-ITD Positive Acute Myeloid Leukemia.

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules

Reconstitution of CD52-Negative CD4 T Cells after Alemtuzumab-Based T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Rapid Detection and Isolation of Viable Virus-Reactive CD4 + and CD8 + T Cells Based on Activation-Induced CD137 Expression.

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Rapid Expansion of Acute Myeloid Leukemia-Reactive Cytotoxic T Cells from CD8+CD62L+ Blood Lymphocytes of HLA-Matched Healthy Donors In Vitro

A PCR-Based Assay for the Detection of Langerhans-Cell Chimerism after Allogeneic Stem Cell Transplantation.

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Characterization of Renal-Cell Carcinoma (RCC)-Reactive Cytotoxic T-Lymphocyte Responses Generated from Peripheral Blood of HLA-Matched Sibling and Unrelated Healthy Individuals in Vitro.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only